ARTICLE | Clinical News
Matritech preclinical data
May 30, 2005 7:00 AM UTC
In 298 blinded serum samples, the qualitative RT-PCR test to detect nuclear matrix protein NMP66 identified over 70% of the cancer sera. The colorimetric assay showed good differentiation of noncancer...